Table 2 Patient characteristics, EMS time metrics, treatment, and outcomes in all AIS and MT groups.
All AIS | p | MT group | p | |||
|---|---|---|---|---|---|---|
Phase I | Phase II | Phase I | Phase II | |||
(n = 53,858) | (n = 59,646) | (n = 1,461) | (n = 3,259) | |||
Age (years), mean (SD) | 75.7 (12.1) | 76.0 (12.1) | < .001 | 73.4 (11.3) | 74.7 (11.6) | < .001 |
Men, n (%) | 30,850 (57.3) | 34,163 (57.3) | 0.989 | 839 (57.4) | 1,839 (56.4) | 0.522 |
JCS score at admission, n (%) | < .001 | 0.010 | ||||
Alert | 18,726 (34.8) | 21,070 (35.3) | 92 (6.3) | 282 (8.7) | ||
Awake | 24,137 (44.8) | 26,988 (45.3) | 633 (43.3) | 1,450 (44.5) | ||
Arousable | 7,021 (13.0) | 7,700 (12.9) | 485 (33.2) | 1,044 (32.0) | ||
Unarousable | 3,974 (7.3) | 3,888 (6.5) | 251 (17.2) | 483 (14.8) | ||
Baseline mRS, median, (min, max) | 1 (0, 3) | 0 (0, 2) | < .001 | 0 (0, 2) | 0 (0, 2) | 0.552 |
Comorbidities | ||||||
Hypertension, n (%) | 32,355 (60.1) | 37,437 (62.8) | < .001 | 1,170 (80.1) | 2,642 (81.1) | 0.427 |
Hyperlipidemia, n (%) | 17,500 (32.5) | 20,370 (34.2) | < .001 | 364 (24.9) | 939 (28.8) | 0.006 |
Diabetes mellitus, n (%) | 11,474 (21.3) | 12,885 (21.6) | 0.222 | 326 (22.3) | 698 (21.4) | 0.490 |
Atrial fibrillation, n (%) | 13,746 (25.5) | 16,439 (27.6) | < .001 | 717 (49.1) | 1,738 (53.3) | 0.007 |
EMS time in min, median (IQR) | ||||||
Response time | 7 (6, 9) | 7 (6, 10) | < .001 | 7 (6, 9) | 7 (6, 9) | 0.168 |
On-scene time | 13 (10, 18) | 13 (10, 18) | < .001 | 14 (10, 18) | 13 (10, 17) | 0.036 |
Transport time | 10 (6, 16) | 10 (7, 16) | < .001 | 10 (6, 16) | 10 (6, 16) | 0.858 |
Total EMS response time | 33 (26, 41) | 33 (27, 42) | < .001 | 33 (26, 41) | 32 (26, 41) | 0.404 |
Outcome (mRS score) | ||||||
0 | 5,790 (10.8) | 6,855 (11.5) | < .001 | 87 (6.0) | 296 (9.1) | < .001 |
1 | 10,050 (18.7) | 11,339 (19.0) | 150 (10.3) | 398 (12.2) | ||
2 | 7,811 (14.5) | 8,851 (14.8) | 182 (12.5) | 419 (12.9) | ||
3 | 6,530 (12.1) | 7,463 (12.5) | 142 (9.7) | 380 (11.7) | ||
4 | 11,508 (21.4) | 12,840 (21.5) | 397 (27.2) | 785 (24.1) | ||
5 | 7,685 (14.3) | 8,154 (13.7) | 287 (19.6) | 638 (20.0) | ||
6 | 4,484 (8.3) | 4,144 (6.9) | 216 (14.8) | 343 (10.5) | ||
Treatment | ||||||
rtPA administration | 5,452 (10.1) | 6,868 (11.5) | < .001 | 782 (53.5) | 1,763 (54.1) | 0.716 |
MT | 1,461 (2.7) | 3,529 (5.5) | < .001 | 1,461 (100) | 3,529 (100) | |
Device, n (%) | ||||||
Stent retriever | 433 (29.6) | 2,275 (69.8) | < .001 | |||
Penumbra | 1,079 (73.9) | 2,124 (65.2) | < .001 | |||
Merci | 196 (13.4) | 6 (0.2) | < .001 | |||
Population density, person/km2 | < .001 | 0.101 | ||||
< 300 | 14,762 (27.9) | 15,148 (25.7) | 303 (20.7) | 702 (21.6) | ||
300–1000 | 15,489 (29.3) | 18,020 (30.6) | 409 (28.0) | 988 (30.4) | ||
> 1000 | 22,685 (42.9) | 15,761 (43.7) | 748 (51.2) | 1,556 (47.9) | ||